1,4-Dihydropyrazolo[4,3-d]imidazole phenyl derivatives: A novel type II Raf kinase inhibitors

A series 1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives and their antiproliferative activities against A375P human melanoma cell line and WM3629 cell line were described.